AAN 2024: new pooled data highlights efficacy of Axsome Therapeutics’s AXS-07
On 15 April, at the American Academy of Neurology (AAN) 2024, Axsome Therapeutics presented new pooled data from two Phase III trials, MOMENTUM (NCT0389600) and INTRCEPT (NCT04163185), evaluating AXS-07 (Molecular Solubility Enhanced Inclusion Complex [ …